Delivery Order SPE2DB22D3011-SPE2DB25FQ2QM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,020.97. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.80 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count packaging) on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,794.96 for Rifampin 300 mg capsules (60-count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract represents a non-competitive set-aside and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. Rifampin is an antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, making this procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,816.89 on August 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, making...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units, with a contract ceiling value of $2,001.28 and an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $3,232.50 under firm fixed pricing. The order is non-set-aside and will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2QMDelivery Order
The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily for treating tuberculosis and certain other mycobacterial infections, making this a essential pharmaceutical requirement for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999.999 billion through December 2026. This prime vendor agreement enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's role as a major pharmaceutical distributor and critical federal medical procurement vendor positions it to fulfill such specialized pharmaceutical needs across the Defense Health Agency and other government healthcare systems, demonstrating the company's consistent capability to meet open competition federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 9/8/25 |